Community Acquired Pneumonia Guidelines
Diagnose, treat, and prevent community acquired pneumonia using key recommendations from the IDSA/ATS CAP guidelines.
Respiratory Diseases/Disorders
Effect of PEEP in COVID-19-Related ARDS Similar to Classical ARDS
The effects of positive end expiratory pressure in COVID-19-related acute respiratory distress syndrome (ARDS) are similar to those reported in classical ARDS.
Decrease in Antibodies to SARS-CoV-2 Seen Over 60 Days Among Health Care Personnel
Investigators conducted a single-center study to evaluate the anti-SARS-CoV-2 antibodies at baseline and 60 days in health care personnel, who are at particular risk if antibodies level decline.
Pneumomediastinum May Increase Mortality in COVID-19 Pneumonia
Pneumomediastinum, although a rare phenomenon, is more prevalent in patients with COVID-19 compared with historical patients with adult respiratory distress syndrome.
Combination Antibody Therapy Reduces Viral Load, COVID-19 Hospitalizations
An interim analysis of the phase 2 study evaluated the combination therapy in recently diagnosed patients with mild to moderate COVID-19.
Methyl-Prednisolone Pulses May Improve COVID-19 Pneumonia Prognosis
Patients with severe COVID-19 pneumonia had improved prognosis after receiving a short course of methyl-prednisolone pulses during the second week of disease.
Trial Evaluating Anti-SARS-CoV-2 Hyperimmune Globulin Begins
The antibody solution is derived from plasma donated by healthy individuals who have recovered from COVID-19.
Antibody Therapy VIR-7831 Enters Phase 3 for Outpatient COVID-19 Treatment
The second part of the study will assess the efficacy and safety of a single intravenous infusion of VIR-7831 in approximately 1300 patients.
COVID-19 Diagnosis Increases Hospitalization Risk in People With Liver Transplant
Although hospitalization risk was higher, mortality, thrombosis, and ICU admission risks were the same in patients with and without liver transplants.
Management of Remdesivir-Associated Acute Liver Failure Examined in Case Series
Remdesivir was immediately discontinued in both patients and a continuous infusion of acetylcysteine was initiated.
-
Loading...
-
Loading...
Next post in COVID19
